HNRNPUL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.696200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.025700E-02
Normal-vs-Stage2
3.883600E-01
Normal-vs-Stage3
1.041160E-01
Normal-vs-Stage4
8.329000E-01
Stage1-vs-Stage2
5.079900E-02
Stage1-vs-Stage3
3.688800E-01
Stage1-vs-Stage4
1.303370E-01
Stage2-vs-Stage3
8.471800E-02
Stage2-vs-Stage4
2.033600E-01
Stage3-vs-Stage4
6.635500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.472400E-01
Normal-vs-AfricanAmerican
7.418000E-01
Normal-vs-Asian
3.930000E-01
Caucasian-vs-AfricanAmerican
4.027000E-01
Caucasian-vs-Asian
8.271800E-01
AfricanAmerican-vs-Asian
5.277400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.002200E-01
Normal-vs-Female
3.496200E-01
Male-vs-Female
7.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.298400E-01
Normal-vs-Age(41-60Yrs)
6.824000E-01
Normal-vs-Age(61-80Yrs)
3.046000E-01
Normal-vs-Age(81-100Yrs)
3.926100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.816000E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.551220E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.612600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.572170E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.602300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.035900E-02
Normal-vs-Daily Drinker
3.151000E-01
Normal-vs-Weekly Drinker
3.593200E-01
Normal-vs-Occasional Drinker
9.307200E-01
Normal-vs-Social Drinker
3.188800E-01
Non Drinker-vs-Daily Drinker
1.435010E-01
Non Drinker-vs-Weekly Drinker
1.315000E-01
Non Drinker-vs-Occasional Drinker
5.383800E-03
Non Drinker-vs-Social Drinker
8.165700E-02
Daily Drinker-vs-Weekly Drinker
8.354200E-01
Daily Drinker-vs-Occasional Drinker
1.321250E-01
Daily Drinker-vs-Social Drinker
7.259400E-01
Weekly Drinker-vs-Occasional Drinker
2.436400E-01
Weekly Drinker-vs-Social Drinker
9.037400E-01
Occasional Drinker-vs-Social Drinker
2.495600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.747400E-01
Normal-vs-Grade 2
7.049800E-01
Normal-vs-Grade 3
6.555200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.468800E-01
Grade 1-vs-Grade 3
2.768800E-01
Grade 1-vs-Grade 4
3.747400E-01
Grade 2-vs-Grade 3
2.209400E-01
Grade 2-vs-Grade 4
7.049800E-01
Grade 3-vs-Grade 4
6.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.441560E-01
Normal-vs-NonDiabetic
4.033600E-01
Diabetic-vs-NonDiabetic
7.807600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.391410E-01
Normal-vs-NoPancreatitis
3.459600E-01
Pancreatitis-vs-NoPancreatitis
5.039000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.972600E-01
Normal-vs-N1
4.054400E-01
N0-vs-N1
9.213600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.776600E-01
Normal-vs-TP53-NonMutant
4.519400E-01
TP53-Mutant-vs-TP53-NonMutant
7.858900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
